Navigation Links
Florida Youth Named National Epilepsy Spokesperson
Date:3/14/2008

Nyle Fenster to Visit Washington, D.C., and Meet with Elected Officials

WASHINGTON, March 14 /PRNewswire-USNewswire/ -- Nyle Fenster of Aventura, Fla., will travel to Washington, D.C., this April 1 to meet with congressional leaders and gain their support for restoration of the Americans with Disabilities Act, support for epilepsy public health programs and more research toward a cure for epilepsy.

Fenster is one of 50 young people with epilepsy participating in Kids Speak Up!, a national program coordinated by the Epilepsy Foundation with support from Abbott. The program rallies young ambassadors with epilepsy between the ages of 7 and 16 to advocate for the more than 3 million Americans living with the condition.

"Nyle was selected to participate in Kids Speak Up! to represent the approximately 350,000 children under the age of 17 who are affected by the condition. He is an ideal candidate because of his desire to achieve his goals despite his challenges. Nyle's courage is an inspiration to us all," said Eric R. Hargis, President and CEO of the Epilepsy Foundation.

This year's participants are a diverse group ranging from those with controlled seizures to those who are massively affected by their epilepsy.

Despite their individual challenges, the kids enjoy doing ordinary things, so when they come to D.C., besides meeting with their leaders, they will be treated to a magic show featuring award-winning magician Bradley Fields and meet Mighty Mike Simmel, an entertainment basketball player of the world famous Harlem Wizards. Simmel, who also has epilepsy, inspires young people to follow their dreams despite their obstacles.

Epilepsy is the most common neurological condition in children and each year approximately 45,000 children under age 17 are diagnosed with the disorder. Despite modern therapy, about one million people in the U.S. continue to experience seizures or significant side effects from treatment for their epilepsy.

About the Epilepsy Foundation

The Epilepsy Foundation, a national non-profit with affiliated organizations throughout the United States, has led the fight against epilepsy since 1968. The Foundation's goals are to ensure that people with seizures are able to participate in all life experiences; and prevent, control and cure epilepsy through services, education, advocacy and research, so not another moment is lost to seizures. For additional information, please visit http://www.epilepsyfoundation.org.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 60,000 people and markets its products in more than 130 countries.


'/>"/>
SOURCE Epilepsy Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Scripps Florida awarded $7.6 million grant to develop novel treatment for Parkinsons disease
2. Hospital Leaders Urge Legislators Not to Further Destabilize Floridas Healthcare Landscape
3. Deadline Extended for Essay Submissions to the FSDDS Sun Defense Essay Contest Throughout Florida Elementary Schools
4. South Florida Gynecologic Oncologists Begin Using LUMA(R) Cervical Pre-Cancer Imaging Device
5. Florida Orange Juice Adds a Healthy Splash of Flavor and Sunshine to Recipes
6. Healthy Start of Southwest Florida Receives Grant From March of Dimes to Assess Needs of Pregnant Women and Babies
7. The Centers for Medicare & Medicaid Services Extends LifeMasters Demonstration Project in Florida
8. Florida Tissue Services Receives National Accreditation
9. Congressman Buchanan Tours Florida Clinical Laboratory; Learns Vital Role in Patient Care
10. Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
11. New Poll Gauges South Floridas Views on Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health ... technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing ... form that can be easily incorporated into liquid products, while reducing costs to end ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , ... mock evacuation of the facility as part of a disaster drill on October 3rd. ... EMS and Shelton City Emergency Manager, as well as the Connecticut Long Term ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... PHILADELPHIA , Oct. 2, 2017 Halo Labs announces ... particle analysis system called the HORIZON at MIBio 2017 in ... analyzes subvisible and visible particulate matter in biopharmaceutical samples with unprecedented ... use of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: